Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-458244

Co-Chief Executive Officer sold 100,000 shares at an average $29.84 ($2,983,678)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Cohen Joshua B Co-Chief Executive Officer 2026-11-09 Sale 10b5-1 −38,105 $29.39 $1,120,032 3,575,018 D
Cohen Joshua B Co-Chief Executive Officer 2026-11-09 Sale 10b5-1 −61,895 $30.11 $1,863,646 3,513,123 D
Open-market sales · 100,000 sh · avg $29.84 · $2,983,678
Loading xslF345X06/ownership.xml…